May bone-targeted radionuclide therapy overcome PRRT-refractory osseous disease in NET? A pilot report on (188)Re-HEDP treatment in progressive bone metastases after (177)Lu-octreo...

Por Sabet, Amir, Khalaf, Feras, Mahjoob, Soha, Al-Zreiqat, Abdullah, Biersack, Hans-Jürgen, Ezziddin, Samer
Publicado em 2013

Bone metastases in GEP-NET: response and long-term outcome after PRRT from a follow-up analysis

Por Sabet, Amir, Khalaf, Feras, Haslerud, Torjan, Al-Zreiqat, Abdullah, Sabet, Amin, Simon, Birgit, Pöppel, Thorsten D, Biersack, Hans-Jürgen, Ezziddin, Samer
Publicado em 2013